Prostate Cancer
Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer.
July 15, 2024
Impact of Anti-Discrimination Legislation on Access to Gender-affirming Care: A Commercial Claims Analysis
July 12, 2024
Clinically relevant humanized mouse models of metastatic prostate cancer facilitate therapeutic evaluation.
July 12, 2024
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer.
July 12, 2024
GE HealthCare’s MIM Software Introduces MIM Symphony HDR Prostate for MR Image Guidance During Procedures
July 11, 2024
Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution.
July 11, 2024